Stroke:中国千人原创研究:血清补体C3水平,可有效预测缺血性脑卒中的预后

2021-03-05 Freeman MedSci原创

血清补体C3水平 可有效预测缺血性脑卒中的预后

 

补体系统(Complement system)又称补体级联,是先天性免疫系统的重要组成部分,具有保护宿主免受微生物入侵、清除免疫复合物、维持组织平衡的功能。

除此以外,补体系统的防御功能还可以加重各种病理状态下的免疫、炎症和退行性反应。补体系统可通过3种途径(经典途径、凝集素途径和替代途径)激活,并受众多可溶性和膜结合型补体调节蛋白的调节。

补体C3作为最丰富的补体蛋白,是3种补体激活途径的汇聚点,也是炎症反应的主要介质6,有报道称补体C3的激活在脑缺血后的脑损伤中起着举足轻重的作用,抑制补体的激活可以减少脑梗死的体积。

一些临床研究也表明,循环补体C3水平升高与血管疾病风险增加有关,缺血性脑卒中后循环补体C3水平明显升高。然而,循环补体C3对缺血性卒中预后的影响仍不明确。

缺血性脑卒中患者中准确的风险分层对于快速优化患者的护理和管理具有重要意义,但既有的传统风险因素(如高血压、糖尿病和血脂异常)不能完全解释缺血性脑卒中的不良预后。

因此,需要鉴定能够改善缺血性卒中后不良临床结局预测的新型生物标志物。


藉此,苏州大学的Pinni Yang等人基于CATIS(China Antihypertensive Trial in Acute Ischemic Stroke)前瞻性地研究了缺血性脑卒中患者大队列中血清补体C3与死亡、主要残疾和血管事件之间的关系。

他们对26家参与医院的3474名缺血性脑卒中患者的血清补体C3水平进行了测定,并收集了缺血性脑卒中后3个月的临床结果数据。主要结果是卒中发病后3个月死亡和主要残疾(mRS≥3分)的复合结果,次要结果包括主要残疾、死亡和血管事件。

结果显示:在3个月的随访中,866名参与者(25.4%)出现主要结局。

多变量调整后,当比较2个极端分位数时,血清补体C3水平升高与主要结局风险增加相关(OR 1.30,P=0.038)。对数转化补体C3每增加一个SD与13%(95%CI 2%-25%)的主要结局风险增加相关。多

变量调整后的Spline回归模型显示:血清补体C3与原发结局风险之间呈线性关系(Plinearity=0.022)。在常规危险因素的基础上加入血清补体C3,显著提高了对原发结局的风险预测这个研究的重要意义在于发现了,基线时高血清补体C3水平与缺血性卒中后3个月不良临床结局风险增加相关,这提示血清补体C3或可成为有价值的生物标志物去预测缺血性卒中。

原文出处

Yang, P., Zhu, Z., Zang, Y., Bu, X., Xu, T., Zhong, C., ... & He, J. (2021). Increased Serum Complement C3 Levels Are Associated With Adverse Clinical Outcomes After Ischemic Stroke. _Stroke_, STROKEAHA-120.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1807151, encodeId=db6b180e151da, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Sep 06 12:56:12 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648505, encodeId=d3881648505f3, content=<a href='/topic/show?id=583e9011ea0' target=_blank style='color:#2F92EE;'>#补体C3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90117, encryptionId=583e9011ea0, topicName=补体C3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sat Jan 01 13:56:12 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893358, encodeId=af7a189335878, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 04 13:56:12 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976254, encodeId=769a9e62549e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83ercDibcW6t8vAM13WMwJKNEuHQVpZC8OtIox9OfLzQ8KaJEUZicumQbqwuDg8rhInkmX2ZKTmKqQuqA/0, createdBy=a2e32191156, createdName=ms586871803353426592, createdTime=Wed Jun 23 16:05:41 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945620, encodeId=028d945620d6, content=应该有点意义,但是不会很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ7zQm4ddHnQZtMr5YoIyahibSYGpicAaLvbuBZEAibuCEqoxc5JgFch7qaRgcxOUKe3XK7VfHQbUJpw/132, createdBy=d98e2444050, createdName=汪亚东, createdTime=Fri Mar 05 08:24:16 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945619, encodeId=498c9456199a, content=不明确, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 08:19:05 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026781, encodeId=b8b31026e8110, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 05 07:56:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945600, encodeId=9c4894560073, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc915465725, createdName=ms2000001920907590, createdTime=Fri Mar 05 06:16:12 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1807151, encodeId=db6b180e151da, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Sep 06 12:56:12 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648505, encodeId=d3881648505f3, content=<a href='/topic/show?id=583e9011ea0' target=_blank style='color:#2F92EE;'>#补体C3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90117, encryptionId=583e9011ea0, topicName=补体C3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sat Jan 01 13:56:12 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893358, encodeId=af7a189335878, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 04 13:56:12 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976254, encodeId=769a9e62549e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83ercDibcW6t8vAM13WMwJKNEuHQVpZC8OtIox9OfLzQ8KaJEUZicumQbqwuDg8rhInkmX2ZKTmKqQuqA/0, createdBy=a2e32191156, createdName=ms586871803353426592, createdTime=Wed Jun 23 16:05:41 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945620, encodeId=028d945620d6, content=应该有点意义,但是不会很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ7zQm4ddHnQZtMr5YoIyahibSYGpicAaLvbuBZEAibuCEqoxc5JgFch7qaRgcxOUKe3XK7VfHQbUJpw/132, createdBy=d98e2444050, createdName=汪亚东, createdTime=Fri Mar 05 08:24:16 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945619, encodeId=498c9456199a, content=不明确, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 08:19:05 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026781, encodeId=b8b31026e8110, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 05 07:56:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945600, encodeId=9c4894560073, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc915465725, createdName=ms2000001920907590, createdTime=Fri Mar 05 06:16:12 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1807151, encodeId=db6b180e151da, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Sep 06 12:56:12 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648505, encodeId=d3881648505f3, content=<a href='/topic/show?id=583e9011ea0' target=_blank style='color:#2F92EE;'>#补体C3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90117, encryptionId=583e9011ea0, topicName=补体C3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sat Jan 01 13:56:12 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893358, encodeId=af7a189335878, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 04 13:56:12 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976254, encodeId=769a9e62549e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83ercDibcW6t8vAM13WMwJKNEuHQVpZC8OtIox9OfLzQ8KaJEUZicumQbqwuDg8rhInkmX2ZKTmKqQuqA/0, createdBy=a2e32191156, createdName=ms586871803353426592, createdTime=Wed Jun 23 16:05:41 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945620, encodeId=028d945620d6, content=应该有点意义,但是不会很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ7zQm4ddHnQZtMr5YoIyahibSYGpicAaLvbuBZEAibuCEqoxc5JgFch7qaRgcxOUKe3XK7VfHQbUJpw/132, createdBy=d98e2444050, createdName=汪亚东, createdTime=Fri Mar 05 08:24:16 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945619, encodeId=498c9456199a, content=不明确, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 08:19:05 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026781, encodeId=b8b31026e8110, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 05 07:56:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945600, encodeId=9c4894560073, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc915465725, createdName=ms2000001920907590, createdTime=Fri Mar 05 06:16:12 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1807151, encodeId=db6b180e151da, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Sep 06 12:56:12 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648505, encodeId=d3881648505f3, content=<a href='/topic/show?id=583e9011ea0' target=_blank style='color:#2F92EE;'>#补体C3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90117, encryptionId=583e9011ea0, topicName=补体C3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sat Jan 01 13:56:12 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893358, encodeId=af7a189335878, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 04 13:56:12 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976254, encodeId=769a9e62549e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83ercDibcW6t8vAM13WMwJKNEuHQVpZC8OtIox9OfLzQ8KaJEUZicumQbqwuDg8rhInkmX2ZKTmKqQuqA/0, createdBy=a2e32191156, createdName=ms586871803353426592, createdTime=Wed Jun 23 16:05:41 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945620, encodeId=028d945620d6, content=应该有点意义,但是不会很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ7zQm4ddHnQZtMr5YoIyahibSYGpicAaLvbuBZEAibuCEqoxc5JgFch7qaRgcxOUKe3XK7VfHQbUJpw/132, createdBy=d98e2444050, createdName=汪亚东, createdTime=Fri Mar 05 08:24:16 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945619, encodeId=498c9456199a, content=不明确, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 08:19:05 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026781, encodeId=b8b31026e8110, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 05 07:56:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945600, encodeId=9c4894560073, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc915465725, createdName=ms2000001920907590, createdTime=Fri Mar 05 06:16:12 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-06-23 ms586871803353426592

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1807151, encodeId=db6b180e151da, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Sep 06 12:56:12 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648505, encodeId=d3881648505f3, content=<a href='/topic/show?id=583e9011ea0' target=_blank style='color:#2F92EE;'>#补体C3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90117, encryptionId=583e9011ea0, topicName=补体C3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sat Jan 01 13:56:12 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893358, encodeId=af7a189335878, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 04 13:56:12 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976254, encodeId=769a9e62549e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83ercDibcW6t8vAM13WMwJKNEuHQVpZC8OtIox9OfLzQ8KaJEUZicumQbqwuDg8rhInkmX2ZKTmKqQuqA/0, createdBy=a2e32191156, createdName=ms586871803353426592, createdTime=Wed Jun 23 16:05:41 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945620, encodeId=028d945620d6, content=应该有点意义,但是不会很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ7zQm4ddHnQZtMr5YoIyahibSYGpicAaLvbuBZEAibuCEqoxc5JgFch7qaRgcxOUKe3XK7VfHQbUJpw/132, createdBy=d98e2444050, createdName=汪亚东, createdTime=Fri Mar 05 08:24:16 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945619, encodeId=498c9456199a, content=不明确, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 08:19:05 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026781, encodeId=b8b31026e8110, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 05 07:56:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945600, encodeId=9c4894560073, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc915465725, createdName=ms2000001920907590, createdTime=Fri Mar 05 06:16:12 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 汪亚东

    应该有点意义,但是不会很大。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1807151, encodeId=db6b180e151da, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Sep 06 12:56:12 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648505, encodeId=d3881648505f3, content=<a href='/topic/show?id=583e9011ea0' target=_blank style='color:#2F92EE;'>#补体C3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90117, encryptionId=583e9011ea0, topicName=补体C3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sat Jan 01 13:56:12 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893358, encodeId=af7a189335878, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 04 13:56:12 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976254, encodeId=769a9e62549e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83ercDibcW6t8vAM13WMwJKNEuHQVpZC8OtIox9OfLzQ8KaJEUZicumQbqwuDg8rhInkmX2ZKTmKqQuqA/0, createdBy=a2e32191156, createdName=ms586871803353426592, createdTime=Wed Jun 23 16:05:41 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945620, encodeId=028d945620d6, content=应该有点意义,但是不会很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ7zQm4ddHnQZtMr5YoIyahibSYGpicAaLvbuBZEAibuCEqoxc5JgFch7qaRgcxOUKe3XK7VfHQbUJpw/132, createdBy=d98e2444050, createdName=汪亚东, createdTime=Fri Mar 05 08:24:16 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945619, encodeId=498c9456199a, content=不明确, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 08:19:05 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026781, encodeId=b8b31026e8110, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 05 07:56:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945600, encodeId=9c4894560073, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc915465725, createdName=ms2000001920907590, createdTime=Fri Mar 05 06:16:12 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 神盾医疗局局长Jack

    不明确

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1807151, encodeId=db6b180e151da, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Sep 06 12:56:12 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648505, encodeId=d3881648505f3, content=<a href='/topic/show?id=583e9011ea0' target=_blank style='color:#2F92EE;'>#补体C3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90117, encryptionId=583e9011ea0, topicName=补体C3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sat Jan 01 13:56:12 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893358, encodeId=af7a189335878, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 04 13:56:12 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976254, encodeId=769a9e62549e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83ercDibcW6t8vAM13WMwJKNEuHQVpZC8OtIox9OfLzQ8KaJEUZicumQbqwuDg8rhInkmX2ZKTmKqQuqA/0, createdBy=a2e32191156, createdName=ms586871803353426592, createdTime=Wed Jun 23 16:05:41 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945620, encodeId=028d945620d6, content=应该有点意义,但是不会很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ7zQm4ddHnQZtMr5YoIyahibSYGpicAaLvbuBZEAibuCEqoxc5JgFch7qaRgcxOUKe3XK7VfHQbUJpw/132, createdBy=d98e2444050, createdName=汪亚东, createdTime=Fri Mar 05 08:24:16 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945619, encodeId=498c9456199a, content=不明确, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 08:19:05 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026781, encodeId=b8b31026e8110, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 05 07:56:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945600, encodeId=9c4894560073, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc915465725, createdName=ms2000001920907590, createdTime=Fri Mar 05 06:16:12 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1807151, encodeId=db6b180e151da, content=<a href='/topic/show?id=245de9378aa' target=_blank style='color:#2F92EE;'>#缺血性脑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79378, encryptionId=245de9378aa, topicName=缺血性脑)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Mon Sep 06 12:56:12 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648505, encodeId=d3881648505f3, content=<a href='/topic/show?id=583e9011ea0' target=_blank style='color:#2F92EE;'>#补体C3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90117, encryptionId=583e9011ea0, topicName=补体C3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Sat Jan 01 13:56:12 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893358, encodeId=af7a189335878, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 04 13:56:12 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976254, encodeId=769a9e62549e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83ercDibcW6t8vAM13WMwJKNEuHQVpZC8OtIox9OfLzQ8KaJEUZicumQbqwuDg8rhInkmX2ZKTmKqQuqA/0, createdBy=a2e32191156, createdName=ms586871803353426592, createdTime=Wed Jun 23 16:05:41 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945620, encodeId=028d945620d6, content=应该有点意义,但是不会很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ7zQm4ddHnQZtMr5YoIyahibSYGpicAaLvbuBZEAibuCEqoxc5JgFch7qaRgcxOUKe3XK7VfHQbUJpw/132, createdBy=d98e2444050, createdName=汪亚东, createdTime=Fri Mar 05 08:24:16 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945619, encodeId=498c9456199a, content=不明确, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 08:19:05 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026781, encodeId=b8b31026e8110, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 05 07:56:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945600, encodeId=9c4894560073, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc915465725, createdName=ms2000001920907590, createdTime=Fri Mar 05 06:16:12 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 ms2000001920907590

    很好👍

    0

相关资讯

Stroke:中性粒细胞与淋巴细胞比值可预测脑卒中患者再灌注治疗后早期脑水肿和临床恶化

全身炎症与卒中再灌注治疗后早期CED的严重程度有关。容易获得的炎症标志物有可能为严重神经系统并发症并影响长期功能结局的患者传递了早期预警信息。

Stroke:D-二聚体水平可提前预测大血管闭塞

D-二聚体水平可提前预测大血管闭塞

Stroke:波形蛋白和脑卒中的发生率正相关

波形蛋白和脑卒中的发生率正相关

Stroke:脑卒中病变部位与抑郁症状之间的相关性分析

左腹外侧前额叶皮层病变增加了卒中后抑郁症状的风险。大脑右侧半球内的病变与抑郁症状无关。认识到左额叶病变是危险因素,应通过更好的危险分层来帮助早期诊断卒中后抑郁。

JACC:糖尿病前期也可增加非瓣膜性房颤患者的卒中风险

糖尿病(DM)可增加非瓣膜性心房颤动(NVAF)的栓塞风险,糖尿病前期是否也会增加这类患者的栓塞风险?

Stroke: 脑容量越大,脑中风预后越好!

脑容量越大,脑中风预后越好!